Companies/US/NHI

NATIONAL HEALTH INVESTORS, INC.

Last · NYSE$70.88-1.03 (-1.43%)stale · yahoo · 99h ago
Market cap$3.48B49.1M sh
P/E · TTM20.5fwd 21.8 · eps 3.46
Beta0.55vs S&P 500
Div yield5.30%annual · TTM
52w range
$67.94$91.38
Volume193.9Ksession

Issuer

Legal nameNATIONAL HEALTH INVESTORS, INC.
HQUnited States (US)
ListingUS NHI
ISINUS63633D1046
SectorReal Estate
IndustryR.E.I.T.
SIC6798
CurrencyUSD
Entity registrysec:0000877860
CIK0000877860
LinkedIn
Employees32
AddressNational Health Investors, Inc. 222 Robert Rose Drive 37129, Murfreesboro +615 890 9100
Loading chart…

OpenFilings analyst

Our analyst

Agentic read of the latest earnings call — recommendation updates when we process a new transcript. Research synthesis, not investment advice.

Latest call · Q2 2026

Hold/watch rather than buy aggressively.

NHI has a credible capital-recycling and SHOP expansion story—SHOP NOI rose 188.5% to $11 million, liquidity was $792.4 million, and the $560 million NHC sale should materially strengthen the balance sheet—but normalized FFO fell 2.5% to $1.19 and same-store SHOP NOI declined 6.3%. The key tension is that FY 2026 FFO guidance of $4.74-$4.79 assumes $180 million of unidentified investments while management is entering a more competitive market at 6%-6.5% yields and still needs to repair occupancy.

Themes
  • Shop Expansion
  • Nhc Disposition
  • Senior Housing Acquisitions
  • Same Store Noi
  • 1031 Reinvestment
  • Occupancy Recovery
+2

Near term

Execution of the $334 million of remaining NHC proceeds through tax-deferred 1031 reinvestment is central; management wants to avoid a special dividend, but has not identified sufficient accretive transactions.

Third- and fourth-quarter same-store SHOP performance must improve sharply to support full-year guidance; management implied approximately 8%-9% second-half same-store NOI growth despite first-half weakness.

The planned pruning of a subset of underperforming same-store SHOP assets could improve returns, but deal scope, timing and financial impact remain undisclosed.

The $127.3 million signed-LOI pipeline, primarily SHOP at a 6.8% initial yield and 6.5% after maintenance CapEx, provides near-term deployment visibility but is below recent 7.7% year-to-date investment yields.

Longer term

Management targets increasing SHOP exposure from approximately 24%-25% of invested capital to 40%-50% over three years, with acquisition capacity targeted at $500 million-$700 million annually versus the prior $200 million-$400 million run rate.

The strategic shift increases exposure to operating execution rather than fixed contractual rent. The new COO and additional systems may improve asset oversight, but G&A already rose 44% to $8.8 million and the cost base is being built ahead of earnings.

Triple-net fundamentals remain a useful stabilizer: cash lease revenue increased 2.8%, senior housing EBITDARM coverage improved to 1.62x, and SNF coverage improved to 2.66x.

Competitive pricing is deteriorating: management said high-quality senior housing yields have moved from roughly 7% to 6%-6.5% in six months, compressing the margin of safety on acquisitions.

Red flags

Management did not quantify the subset of same-store SHOP assets under strategic review or provide a firm announcement timeline beyond wanting action this year.

The full-year FFO outlook depends on $180 million of unidentified new investments, creating execution and underwriting risk if attractive deals are unavailable or are acquired at lower yields.

Same-store SHOP NOI remains below prior year, with one property suffering occupancy pressure from offline units and recent excess deaths also weighing on move-ins.

Analysts pressed on why NHI's targeted SHOP growth of 8%-10% trails peers reporting low- to mid-teens growth; management cited a more conservative, light-value-add strategy but did not provide evidence that the newer portfolio can outperform the stated range.

The proposed increase in operating exposure is not yet matched by demonstrated same-store performance: newer assets are said to be within assumptions, but the legacy portfolio continues to require occupancy and pricing remediation.

The NHC gain of approximately $541.6 million will boost reported earnings but is not recurring cash-flow growth; normalized FFO was down and interest expense rose 5.4%.

Forward outlook

eps diluted

4.74–4.79 $per share

FY 2026

official guidance

ebitda

44.1–45.1 $million

FY 2026

official guidance

OpenFilings analyst view from primary-source filings and earnings calls — not investment advice.

Recent earnings

1 event
Reported · 9:00 PM UTC+1
Period
Jun 2026
EPS
$1.15Missed−74.82%
Est. revenue
107.7M

Earnings transcripts

4 recent

Documents